Filing Details
- Accession Number:
- 0001140361-12-052551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-21 19:31:44
- Reporting Period:
- 2012-12-19
- Filing Date:
- 2012-12-21
- Accepted Time:
- 2012-12-21 19:31:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1388111 | Rajiv Malik | 1500 Corporate Drive Canonsburg PA 15317 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-12-19 | 100,000 | $11.18 | 285,255 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-12-19 | 100,000 | $27.81 | 185,255 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option Right to Buy | Disposition | 2012-12-19 | 100,000 | $0.00 | 100,000 | $11.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-03-18 | 2018-03-18 | No | 4 | M | Direct |
Footnotes
- Represents the weighted price of the reporting person's disposition of 100,000 shares in transactions ranging from $27.52 to $28.34.
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
- This option exercise and the related sale were executed pursuant to a 10b5-1 trading plan dated December 12, 2012.